Form D · Pharmaceuticals
Bellerophon Therapeutics, Inc.
Warren, NJ · CIK 0001600132
Offering snapshot reported Oct 11, 2017 · SEC filing
- Reported sold
- $23.4M Offering amount: $23.4M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 29, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 11, 2017 | Initial | $23,437,050 | No comparison | 11 | SEC filing |
| May 19, 2017 | Initial | $1,612,500 | No comparison | 7 | SEC filing |
| Jul 2, 2014 | Initial | $1 | No comparison | 6 | SEC filing |
| Feb 21, 2014 | Initial | $1 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $650K
- Finders' fees
- $0
- Form D file number
- 021-296368
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Theodore Wang | 2786005 | Angel Pond Capital LLC · CRD 287761 |
Source: Form D, filed Oct 11, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Abrams | Executive |
| Naseem P. Amin | Director |
| Aldo Belloni | Director |
| Scott P. Bruder | Director |
| Mary Ann Cloyd | Director |
| Martin Dekker | Executive |
| Amy Edmonds | Executive |
| Peter Fernandes | Executive |
| Reinilde Heyrman | Executive |
| Matthew Holt | Director |
| Jens Luehring | Director |
| Martin Meglasson | Executive |
| Andre V. Moura | Director |
| Manesh Naidu | Executive |
| Robert Nelsen | Director |
| Jonathan M. Peacock | Director |
| Howard Pien | Director |
| Deborah A. Quinn | Executive |
| Bryan Roberts | Director |
| Megan Schoeps | Executive |
| Parag Shah | Executive |
| Daniel Tasse | Director |
| Fabian Tenenbaum | Director, Executive |
| Adam B. Weinstein | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
184 Liberty Corner Road, Suite 302
Warren, NJ, 07059
Warren, NJ, 07059